Noopept vs Piracetam
Independent, side-by-side comparison of Noopept and Piracetam: mechanism, half-life, dose range, safety profile, and live vendor pricing. Updated continuously as new research and listings land.
Live price snapshot
Noopept
Piracetam
Noopept
Noopept is the common brand and research name for N-phenylacetyl-L-prolylglycine ethyl ester (GVS-111; INN omberacetam), a small dipeptide nootropic developed in the 1990s at the Russian Academy of Medical Sciences'…
Live lowest price: $50.00 across 5 vendors
Full Noopept profilePiracetam
Piracetam is the prototypical nootropic — the compound that inaugurated an entire class of cognitive enhancement drugs and gave the category its name. It was synthesized in 1964 by Romanian-born Belgian chemist Corneliu…
Full Piracetam profileSide-by-side comparison
| Attribute | Noopept | Piracetam |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Noopept's mechanism of action is multifaceted and — despite decades of research — incompletely understood. Several convergent pathways have been proposed, each supported by preclinical data but none definitively established as the primary driver of its… | Piracetam's mechanism of action is the subject of 50+ years of research that has identified several pharmacologic effects without converging on a single primary mechanism. The compound is a cyclic derivative of GABA but has minimal direct GABAergic activity —… |
| Half-Life | — | — |
| Typical Dose Range | — | — |
| Dosing Frequency | — | — |
| Administration | — | — |
| Side Effects | Noopept is generally well tolerated in the Russian clinical literature, with side effects that are typically mild and transient. However, "well tolerated in Russian open-label trials" is a weaker safety claim than the rigorous multi-phase trial data underlying… | Piracetam's side effect profile is among the most favorable in all of pharmacology, which is one of the reasons Giurgea identified it as the prototype for a new class of cognitive enhancement drugs with high safety margins. In 50+ years of clinical use across… |
| Molecular Weight | 318.37 g/mol | — |
| Common Vial Sizes | — | — |
Price History
2 data points- VANDL Labs
- Adera
Noopept — potential benefits
- Memory enhancement
- BDNF/NGF upregulation
- Neuroprotection
- Focus and learning speed
- Anxiety reduction (moderate)
- Anti-amyloid properties
Piracetam — potential benefits
- No structured benefit list published.
Frequently asked
What's the difference between Noopept and Piracetam?
Noopept is a nootropics that noopept's mechanism of action is multifaceted and — despite decades of research — incompletely understood. several convergent pathways have been proposed, each supported by…. Piracetam is a nootropics that piracetam's mechanism of action is the subject of 50+ years of research that has identified several pharmacologic effects without converging on a single primary mechanism. the…. The two differ in mechanism, half-life (not reported vs not reported), and typical dose range.
Which has the longer half-life, Noopept or Piracetam?
Noopept has a half-life of not reported. Piracetam has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Noopept and Piracetam?
Stacking depends on mechanism overlap, safety profile, and goals. Noopept and Piracetam should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Live listings from the vendors we track, refreshed continuously.
Related comparisons
Research use only. BodyHackGuide is an independent research reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks — this never affects the data or pricing shown. See editorial standards and affiliate disclosure.